1. Home
  2. WFCF vs LUNG Comparison

WFCF vs LUNG Comparison

Compare WFCF & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Where Food Comes From Inc.

WFCF

Where Food Comes From Inc.

HOLD

Current Price

$12.45

Market Cap

51.1M

Sector

Technology

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.52

Market Cap

57.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WFCF
LUNG
Founded
1996
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.1M
57.9M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
WFCF
LUNG
Price
$12.45
$1.52
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$5.38
AVG Volume (30 Days)
13.3K
590.9K
Earning Date
05-11-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.64
EPS
0.02
N/A
Revenue
$20,774,416.00
$90,497,000.00
Revenue This Year
N/A
$2.48
Revenue Next Year
N/A
$18.46
P/E Ratio
$657.01
N/A
Revenue Growth
16.69
8.01
52 Week Low
$9.15
$1.13
52 Week High
$22.15
$3.88

Technical Indicators

Market Signals
Indicator
WFCF
LUNG
Relative Strength Index (RSI) 48.96 56.54
Support Level $10.98 $1.22
Resistance Level $12.91 $1.67
Average True Range (ATR) 1.87 0.12
MACD 0.10 0.02
Stochastic Oscillator 24.50 87.50

Price Performance

Historical Comparison
WFCF
LUNG

About WFCF Where Food Comes From Inc.

Where Food Comes From Inc is a third-party food verification company conducting both on-site and desk audits to verify that claims being made about livestock, food, other high-value specialty crops and agricultural and aquaculture products are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. It also provides a wide range of professional consulting services. It generates the majority of its revenue from Verification and certification services.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: